| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/29/2011 | US7914753 Analytical system, and analytical method and flow structure thereof |
| 03/29/2011 | US7914752 On-board control for analytical elements |
| 03/29/2011 | US7914741 Automated microsampling dissolution test system |
| 03/29/2011 | US7914740 Biosensor utilizing a resonator having a functionalized surface |
| 03/29/2011 | US7914735 Use of physical barriers to minimize evaporative heat losses |
| 03/29/2011 | US7914701 Lateral flow diagnostic device that contains a phosphorescent material encapsulated in a crosslinked polymer matrix |
| 03/29/2011 | US7914689 Forming two fraction by centrifuging the multi-component fluid disposed in the container, containing the first fraction in a collection area of a first piston with a selected volume of the second fraction and withdrawing it from the container; kits; whole blood sample, adipose tissue, or bone marrow |
| 03/29/2011 | US7914663 Structure, porous body, sensor, process of structure and detecting method for specimen |
| 03/29/2011 | US7914656 Matrixes, arrays, systems and methods |
| 03/29/2011 | US7914465 Method and apparatus for penetrating tissue |
| 03/29/2011 | US7914449 Diagnostic support system for diabetes and storage medium |
| 03/29/2011 | US7913542 Isolated gas sensor configuration |
| 03/29/2011 | US7913540 Odor screening system |
| 03/29/2011 | CA2624129C Release reagent for vitamin d compounds |
| 03/29/2011 | CA2522378C Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 03/29/2011 | CA2515686C Deglycosylated enzymes for conjugates |
| 03/29/2011 | CA2497988C Quantification of gene expression |
| 03/29/2011 | CA2492438C Lectin pathway deficiency assay |
| 03/29/2011 | CA2447040C Assays, methods and means |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2443146C Genomic dnas involved in rheumatoid arthritis, a method of diagnosing orjudging onset risk of the same, and diagnostic kit for detecting the same |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2370255C Polynucleotide matrix-based method of identifying microorganisms |
| 03/29/2011 | CA2353868C Composite arrays utilizing microspheres |
| 03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 03/29/2011 | CA2344974C Chimaeric proteins between members of tgf-beta superfamily |
| 03/29/2011 | CA2323058C Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression |
| 03/29/2011 | CA2306501C Precision fluorescently dyed particles and methods of making and using same |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/29/2011 | CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment |
| 03/29/2011 | CA2165573C Anti-.alpha.v-integrin monoclonal antibody |
| 03/28/2011 | CA2726154A1 Gas migration test method |
| 03/28/2011 | CA2716281A1 Apparatus and method for determining the center of annual rings of a wood block |
| 03/24/2011 | WO2011035323A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 03/24/2011 | WO2011035274A1 Use of the sparc microenvironment signature in the treatment of cancer |
| 03/24/2011 | WO2011035185A2 A microfluidic device and uses thereof |
| 03/24/2011 | WO2011035177A2 High-throughput screening |
| 03/24/2011 | WO2011035101A1 Diagnostic tests for abnormal ovarian conditions |
| 03/24/2011 | WO2011035097A1 Methods and composition for diagnosis and prognosis of renal injury and renal failure |
| 03/24/2011 | WO2011035083A1 Biomarkers for iap inhibitor compounds |
| 03/24/2011 | WO2011035067A2 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development |
| 03/24/2011 | WO2011035012A2 Methods and compositions for diagnosing heart failure |
| 03/24/2011 | WO2011034978A2 Liquid to liquid biological particle concentrator with disposable fluid path |
| 03/24/2011 | WO2011034846A1 Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion |
| 03/24/2011 | WO2011034766A1 A noninvasive method for measuring histamine from skin as an objective measurment of itch |
| 03/24/2011 | WO2011034668A1 Enzyme triggered redox altering chemical elimination (e-trace) immunoassay |
| 03/24/2011 | WO2011034620A2 Integrated cartridge |
| 03/24/2011 | WO2011034596A1 High-throughput biomarker segmentation utilizing hierarchical normalized cuts |
| 03/24/2011 | WO2011034539A1 Methods for detecting autodigestion |
| 03/24/2011 | WO2011034445A1 Detection of antibodies |
| 03/24/2011 | WO2011034421A1 Fra-1 target genes as drug targets for treating cancer |
| 03/24/2011 | WO2011034182A1 Hepatocellular carcinoma marker |
| 03/24/2011 | WO2011034128A1 Collagen neoepitope antibody |
| 03/24/2011 | WO2011034106A1 Method for isolation of dermal stem cell |
| 03/24/2011 | WO2011034088A1 Identification method and onset prediction method for atherothrombotic cerebral infarction in acute cerebral infarction |
| 03/24/2011 | WO2011033876A1 Blood glucose meter and blood glucose level measurement method |
| 03/24/2011 | WO2011033875A1 Blood glucose meter |
| 03/24/2011 | WO2011033290A2 Dual-fluorescence assay |
| 03/24/2011 | WO2011033283A1 Insect conditioning system |
| 03/24/2011 | WO2011033252A1 Diagnostic agent for parkinson's disease |
| 03/24/2011 | WO2011033249A1 Method and kit for the classification and prognosis of wounds |
| 03/24/2011 | WO2011033241A1 Use of k2p potassium channel activators as antalgics |
| 03/24/2011 | WO2011033046A1 Novel assay for the detection of amyloid beta peptides |
| 03/24/2011 | WO2011033034A1 Multimarker panel for left ventricular hypertrophy |
| 03/24/2011 | WO2011032994A1 Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) |
| 03/24/2011 | WO2011032941A1 Method for carrying out reactions in an analytical device |
| 03/24/2011 | WO2011032722A1 Module-based vector useful in the assessment of antigen-specific t cell functions |
| 03/24/2011 | WO2011032530A1 Disposable device for storing biological liquids and use thereof to detect materials, particles, and/or cells |
| 03/24/2011 | WO2011032296A1 Methods and compositions for the diagnosis and treatment of thyroid cancer |
| 03/24/2011 | WO2011032284A1 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |
| 03/24/2011 | WO2011032279A1 Method for monitoring or tracing operations in well boreholes |
| 03/24/2011 | WO2011032278A1 A method and apparatus for lateral flow determination of analyte concentration |
| 03/24/2011 | WO2011032243A1 Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines |
| 03/24/2011 | WO2011014485A3 Methods to characterize cell reprogramming and uses thereof |
| 03/24/2011 | WO2011012832A3 Method for diagnosing a cancer, for determining the thrombotic risk in an individual stricken with a cancer and for determining the severity of a cancer in an individual |
| 03/24/2011 | WO2011012754A3 Electrochemical sensor for the detection of analytes in liquid media |
| 03/24/2011 | WO2011002157A3 Marker for diagnosing papillary thyroid carcinoma containing 3-indoleacetonitrile as an active ingredient |
| 03/24/2011 | WO2011002152A3 Sensor used together with a detector to measure biomaterial, and apparatus using same |
| 03/24/2011 | WO2010147375A3 Method for screening for substance which inhibits interaction between beta amyloid peptide and vegf and inhibitor searched by same |
| 03/24/2011 | WO2010140763A3 Biosensor |
| 03/24/2011 | WO2010132890A9 Detection of changes in cell populations and mixed cell populations |
| 03/24/2011 | WO2010132795A3 Systems, devices, and methods for specific capture and release of biological sample components |
| 03/24/2011 | WO2010132610A3 Thermoplastic substrates with wrinkled metallic surfaces for chemical and biological sensing |
| 03/24/2011 | WO2010132581A9 Vessel coating and inspection |
| 03/24/2011 | WO2010131127A3 Absorbent articles capable of indicating the presence of urinary tract infections |
| 03/24/2011 | WO2010124257A3 Methods and kits for determining oxygen free radical (ofr) levels in animal and human tissues as a prognostic marker for cancer and other pathophysiologies |
| 03/24/2011 | WO2010123892A3 Swept source optical coherence tomography (oct) method and system |
| 03/24/2011 | WO2010120155A3 Biosensor for diagnosis of disease capable of rapidly separating blood cells |
| 03/24/2011 | WO2010117420A3 Fret-labeled compounds and uses therefor |
| 03/24/2011 | WO2010115210A3 Mouse models |
| 03/24/2011 | WO2010111516A3 Compositions and methods for inhibiting biofilms |
| 03/24/2011 | WO2010108180A3 Citrulline, a risk indicator for cardiovascular disease |
| 03/24/2011 | WO2010108003A3 Device for capturing circulating cells |
| 03/24/2011 | WO2010096385A3 Methods and compositions for the treatment of autoimmune disease |
| 03/24/2011 | WO2010093803A3 Physiological parameter sensors |
| 03/24/2011 | WO2010091793A3 Analyte measurement device with on-strip coding background |
| 03/24/2011 | WO2010052467A3 Canine oral cavity probiotics |
| 03/24/2011 | WO2008116468A8 Mhc peptide complexes and uses thereof in infectious diseases |